| Product NDC: | 65162-751 |
| Proprietary Name: | Benazepril Hydrochloride |
| Non Proprietary Name: | Benazepril Hydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Benazepril Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65162-751 |
| Labeler Name: | Amneal Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076820 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100202 |
| Package NDC: | 65162-751-03 |
| Package Description: | 30 TABLET in 1 BOTTLE (65162-751-03) |
| NDC Code | 65162-751-03 |
| Proprietary Name | Benazepril Hydrochloride |
| Package Description | 30 TABLET in 1 BOTTLE (65162-751-03) |
| Product NDC | 65162-751 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Benazepril Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100202 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal Pharmaceuticals |
| Substance Name | BENAZEPRIL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiontensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |